+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Effexor"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Research Report on China's Venlafaxine Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Venlafaxine Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
Fetzima (levomilnacipran; Allergan) Drug Overview 2019 - Product Thumbnail Image

Fetzima (levomilnacipran; Allergan) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
  • 5 Results (Page 1 of 1)
Loading Indicator

Effexor (venlafaxine) is a medication used to treat mental disorders such as depression, anxiety, and panic disorder. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain. Effexor is available in both immediate-release and extended-release forms. It is usually taken once or twice daily with or without food. Common side effects include nausea, dry mouth, insomnia, and dizziness. The Effexor market is a subset of the larger mental disorders drugs market. It is a competitive market with a variety of different medications available to treat mental disorders. Effexor is one of the most commonly prescribed medications for depression and anxiety. Some companies in the Effexor market include Pfizer, GlaxoSmithKline, and Mylan. Show Less Read more